A study published by David Cheng, Postdoctoral Scientist, Neuroscience Research, University of New South Wales, NSW, Australia, says that CBD has a potential as a preventive measure against symptoms of Alzheimer’s. This presents yet another exciting development for medical researchers, given the persistent challenges to finding effective solutions for this condition.
February of 2017, a Hawaii government committee passed a bill to decriminalize industrial hemp, removed it from the state’s list of controlled substances and excludes growing, possession, processing and the sale of industrial hemp from civil and criminal penalties. No license is needed to grow and the crop is treated as other plants such as tomatoes, fruits, and other vegetables.
The passing of SB 218 through the Kentucky legislature created a new subsection of KRS 260.850m to 260.289, in which the Industrial Hemp Advisory Board outlines the purpose of an industrial hemp research program, establish license provisions, and create new requirements and license application procedures. This state’s approach is for the potential medical and industrial applications.